Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.

The authors conducted a systematic review to assess the effects of 3HP compared with daily 6- or 9-month INH monotherapy

From:
Department for International Development
Published
19 February 2019
Document Type:
Journal Article
Theme:
Health
Authors:
Harries, A.D., Takarinda, K.C.

Abstract

Uptake of preventive treatment for tuberculosis (TB) remains poor. A 3-month regimen of rifapentine (RPT) plus isoniazid (INH) (3HP) could facilitate its scale-up. The authors conducted a systematic review to assess the effects of 3HP compared with daily 6- or 9-month INH monotherapy.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Harries AD, Takarinda KC. F1000Prime Recommendation of [Hamada Y et al., Int J Tuberc Lung Dis 2018 22(12):1422-1428]. F1000Prime. 2019. Available from: https://f1000.com/prime/734764713#eval793556346

Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review

Updates to this page

Published 19 February 2019
Contents